Molecular structure of (S)-(+)-N-3-Benzylnirvanol, CAS Number: 790676-40-3
(S)-(+)-N-3-Benzylnirvanol (CAS 790676-40-3)
See product citations (1)
Alternate Names:
(5S)-(+)-5-Ethyl-5-phenyl-3-(phenylmethyl)-2,4-imidazolidinedione
Application:
(S)-(+)-N-3-Benzylnirvanol is a potent and selective human CYP2C19 inhibitor
CAS Number:
790676-40-3
Purity:
98%
Molecular Weight:
294.35
Molecular Formula:
C18H18N2O2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
(S)-(+)-N-3-Benzylnirvanol is a potent and selective human CYP2C19 inhibitor. It is a chiral compound. In the context of synthetic organic chemistry, (S)-(+)-N-3-Benzylnirvanol serves as an example of how chiral centers influence the reactivity and interaction of molecules with chiral catalysts, enzymes, or chiral stationary phases used in chromatographic separation techniques. The study and application of such chiral compounds are fundamental in achieving high selectivity and efficiency in chemical synthesis and separation processes, which are pivotal in producing enantiomerically pure substances.
(S)-(+)-N-3-Benzylnirvanol (CAS 790676-40-3) References
- Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors. | Suzuki, H., et al. 2004. Arch Biochem Biophys. 429: 1-15. PMID: 15288804
- In vitro metabolism of tributyltin and triphenyltin by human cytochrome P-450 isoforms. | Ohhira, S., et al. 2006. Toxicology. 228: 171-7. PMID: 16978758
- Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements. | Foti, RS., et al. 2008. Xenobiotica. 38: 264-80. PMID: 18274956
- In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes. | Han, YL., et al. 2011. Phytother Res. 25: 1660-5. PMID: 21425377
- Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4. | Ohbuchi, M., et al. 2012. Xenobiotica. 42: 633-40. PMID: 22313038
- In vitro metabolism studies on mephedrone and analysis of forensic cases. | Pedersen, AJ., et al. 2013. Drug Test Anal. 5: 430-8. PMID: 22573603
- In vitro metabolism and pharmacokinetic studies on methylone. | Pedersen, AJ., et al. 2013. Drug Metab Dispos. 41: 1247-55. PMID: 23545806
- Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes. | Bae, SH., et al. 2013. Chem Biol Interact. 205: 11-9. PMID: 23777987
- Metabolism of diosbulbin B in vitro and in vivo in rats: formation of reactive metabolites and human enzymes involved. | Yang, B., et al. 2014. Drug Metab Dispos. 42: 1737-50. PMID: 25053620
- Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11. | Nielsen, LM., et al. 2016. Drug Test Anal. 8: 792-800. PMID: 26360322
- Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes. | Watanabe, M., et al. 2015. Drug Metab Pharmacokinet. 30: 325-33. PMID: 26423799
- Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the in vitro metabolism of tivantinib. | Nishiya, Y., et al. 2016. Xenobiotica. 46: 967-76. PMID: 26899628
- An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure. | Spaggiari, D., et al. 2016. Toxicol Appl Pharmacol. 302: 41-51. PMID: 27105555
Inhibitor of:
CYP2C19.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(S)-(+)-N-3-Benzylnirvanol, 5 mg | sc-220043 | 5 mg | $378.00 |